Clinical Biotec

Mining the Microbiome: Microbiome startups are proliferating, exploring new markets, and colonizing diverse therapeutic niches | Clinical OMICs - Molecular Diagnostics in Personalized Medicine It would be hard to find an area of health where the microbiome has not been implicated as a major player. The microbiome is there even before birth, influencing maternal-child health outcomes, and it lingers, in a fashion, even after death. In between, the microbiome contributes to health, maintain...

Advances in Clinical Research in EcuadorTherapeutic Innovation & Regulatory Science - Thelvia I. Ramos, Karina Alexandra Castro, Luis Santiago Escalante, Nelson Santiago Vispo, 2017 Ecuador is undergoing a process of clinical research development and strengthening. At the turn of the century, Ecuador experienced a favorable transition perio...

Google And Apple Compete For Clinical Trial Supremacy The Apple Watch, along with Apple’s ResearchKit, has already found a home in the clinical space. But it just got some competition. In April...

Sitio Clinical Biotec en Chino / Clinical Biotec site in Chinese
http://clinicalbiotec.com/page-12.html

中国

All for the pharmaceutical industry in Ecuador: from the lab to clinical trials

igeahub.com

Latin America: A Region of Diversity, a World of Opportunity for Clinical Trial Sponsorshttp://www.pharm-olam.com/sites/default/files/poi-clinical-trials_whitepaper-latin-america.pdf

www.pharm-olam.com

FDA seeks feedback on use of EHR data in clinical research | FierceBiotech FDA has posted draft guidance designed to facilitate the use of data from electronic health records in clinical research. The draft addresses the complications that arise from taking data collected and maintained by organizations that exist outside of the scope of FDA oversight, and using them to ba...

http://blogs.fda.gov/fdavoice/index.php/2016/04/2015-an-important-year-for-advancing-generic-drugs-at-fda/

2015: An Important Year for Advancing Generic Drugs at FDA | FDA Voice 2015: An Important Year for Advancing Generic Drugs at FDA Posted on April 13, 2016 by FDA Voice By: Kathleen “Cook” Uhl, M.D. Generic drugs allow greater access to health care for all Americans. At FDA’s Office of Generic Drugs (OGD) in the Center for Drug Evaluation and Research, 2015 was an impor...

Natural speech reveals the semantic maps that tile human cerebral cortex : Nature : Nature... Article preview View full access options Nature | Article Print Share/bookmark Cite U Like Facebook Twitter Delicious Digg Google+ LinkedIn Reddit StumbleUpon 日本語要約 Previous article Nature | Correction Correction Next article Nature | Article Robust neuronal dynamics in premotor cortex during motor…

http://www.diaglobal.org/en/flagship/euromeeting-2016

28th Annual EuroMeeting 2016 | DIA

http://www.who.int/drugresistance/surveillance/es/

Vigilancia de la resistencia a los antimicrobianos En mayo de 2015, la 68.a Asamblea Mundial de la Salud adoptó el Plan de acción mundial sobre la resistencia a los antimicrobianos uno de cuyos cinco objetivos estratégicos consiste en reforzar las evidencias mediante una mejora de la vigilancia y la investigación.

is ready for

For the purposes of registration, a clinical trial is any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.
Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiological procedures, devices, behavioural treatments, process-of-care changes, preventive care, etc.

WHO | Clinical trials Clinical trials: WHO health topic page on clinical trials provides links to descriptions of activities, reports, publications, statistics, news, multimedia and events, as well as contacts and cooperating partners in the various WHO programmes and offices working on this topic.

Drugmaker Sanofi Pasteur launches effort to develop Zika vaccine Drugmaker Sanofi Pasteur said Tuesday it is launching an effort to research and develop a vaccine to prevent the Zika virus, after the World Health Organization declared a global emergency over its explosive spread across the Americas.

FDA approves new drug for treatment of chronic hepatitis C genotypes 1 and 4: http://go.usa.gov/cEefC.

FDA approves Zepatier for treatment of chronic hepatitis C genotypes 1 and 4 The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients.

http://www.fda.gov/Cosmetics/GuidanceRegulation/LawsRegulations/ucm074201.htm

Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?) An overview of the legal differences between cosmetics and drugs, and whether a cosmetic can be both or just a soap.

https://www.facebook.com/hptcongress/

Controlando a la diabetes y sus complicaciones más severas Congreso: Controlando a la diabetes y a sus complicaciones más severas. Del 8 al 12 de Diciembre 20

Nuevas proyecciones de la investigación clínica en Ecuador. Thelvia Ramos http://fb.me/7KhP6xFdi

fb.me

La Dirección Nacional de Inteligencia de la Salud, del MSP del Ecuador generar información, proponer normativas, políticas y lineamientos estratégicos para fortalecer la gestión de la Autoridad Sanitaria Nacional, en los campos referidos a evaluación de tecnología sanitaria, bioética e investigaciones en salud.http://www.salud.gob.ec/direccion-de-inteligencia-de-la-salud/

Ministerio de Salud Pública » Dirección Nacional de Inteligencia de la SaludMinisterio de Salud... // Dirección Nacional de Inteligencia de la Salud Misión Generar información, proponer normativa, políticas y lineamientos estratégicos para fortalecer ...